Corebridge Financial’s Dianthus Therapeutics DNTH Stock Holding History

Corebridge Financial’s Portfolio DNTH Stock Details DNTH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-11,709	Closed	-$212K	–	789
2025 Q1	$212K	Sell	11,709 -174	-1%	-$3.83K	﹤0.01%	2043
2024 Q4	$259K	Sell	11,883 -897	-7%	-$23.1K	﹤0.01%	2020
2024 Q3	$350K	Sell	12,780 -79	-0.6%	-$2.2K	﹤0.01%	1916
2024 Q2	$333K	Buy	+12,859	New	+$309K	﹤0.01%	1910

Other funds holding DNTH

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return

Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return